DLD Asset Management »

Inhibrx Biosciences shares owned by DLD Asset Management

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by DLD Asset Management from 13F filings

Historical chart of DLD Asset Management investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by DLD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by DLD Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $16M 205k 79.06

More positions owned by DLD Asset Management

Echostar Corp Note 3.875%11/3 (Principal)
Stride Note 1.125% 9/0 (Principal)
Ormat Technologies Note 2.500% 7/1 (Principal)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ionis Pharmaceuticals Note 1.750% 6/1 (Principal)
Rivian Automotive Com Cl A Put Option (RIVN)
Progress Software Corp Note 1.000% 4/1 (Principal)
Transocean Deb 4.625% 9/3 (Principal)
Centrus Energy Corp Note 2.250%11/0 (Principal)
Bofa Fin MTNF 0.600% 5/2 (Principal)
Makemytrip Limited Mauritius Note 2/1 (Principal)
Advanced Energy Inds Note 2.500% 9/1 (Principal)
Wolfspeed Note 2.500% 6/1 (Principal)
Starwood Ppty Tr Note 6.750% 7/1 (Principal)
Cidara Therapeutics Com New Call Option (CDTX)

View all positions for DLD Asset Management

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
Sanofi
HighTower Advisors
BlackRock
Susquehanna International
Vanguard Group
Caligan Partners
Sofinnova Ventures
Capital Research Global Investors
State Street Corporation
Millennium Management
Healthcare Of Ontario Pension Plan Trust Fund
Partner Fund Management
Geode Capital Management

View all funds holding Inhibrx Biosciences